NovaBridge Biosciences - NBP

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 29
Latest filed: Apr 22, 2026
Form Count
6-K 23
144 3
6-K/A 2
SCHEDULE 13D/A 1

Latest files

Filed Form Report period Accession SEC
Apr 22, 2026 6-K Apr 22, 2026 0001193125-26-168315 View
Apr 07, 2026 6-K Apr 07, 2026 0001193125-26-145700 View
Mar 18, 2026 144 0001973379-26-000121 View
Mar 16, 2026 6-K Mar 16, 2026 0001193125-26-107313 View
Mar 09, 2026 6-K Mar 09, 2026 0001193125-26-097536 View
Mar 03, 2026 6-K Mar 03, 2026 0001193125-26-086892 View
Feb 25, 2026 6-K Feb 25, 2026 0001193125-26-068546 View
Feb 19, 2026 6-K Feb 19, 2026 0001193125-26-058080 View
Feb 17, 2026 6-K Feb 17, 2026 0001193125-26-054569 View
Feb 06, 2026 6-K Feb 06, 2026 0001193125-26-040355 View
Feb 06, 2026 6-K/A Feb 06, 2026 0001193125-26-041170 View
Feb 03, 2026 SCHEDULE 13D/A 0001193125-26-035559 View
Jan 22, 2026 6-K Jan 22, 2026 0001193125-26-018662 View
Jan 22, 2026 6-K Jan 22, 2026 0001193125-26-019417 View
Jan 16, 2026 6-K Jan 16, 2026 0001193125-26-015342 View
Jan 06, 2026 6-K Jan 06, 2026 0001193125-26-003444 View
Jan 02, 2026 144 0001973379-26-000001 View
Dec 18, 2025 6-K Sep 30, 2025 0001193125-25-323791 View
Dec 18, 2025 144 0001973379-25-000325 View
Dec 10, 2025 6-K Dec 10, 2025 0001193125-25-314328 View
Dec 04, 2025 6-K Dec 03, 2025 0001193125-25-307454 View
Oct 31, 2025 6-K Oct 31, 2025 0001193125-25-259310 View
Oct 30, 2025 6-K Oct 29, 2025 0001193125-25-256922 View
Oct 29, 2025 6-K Oct 29, 2025 0001193125-25-256295 View
Oct 28, 2025 6-K Oct 28, 2025 0001193125-25-253456 View
Oct 24, 2025 6-K/A Oct 24, 2025 0001193125-25-249298 View
Oct 24, 2025 6-K Oct 24, 2025 0001193125-25-249612 View
Oct 24, 2025 6-K Oct 24, 2025 0001193125-25-250009 View
Oct 23, 2025 6-K Oct 23, 2025 0001193125-25-248891 View